136 related articles for article (PubMed ID: 25759883)
1. [Structured care for patients with new oral anticoagulants. Nursing based care of adults with atrial fibrillation].
Al-Khalili F; Lindström C
Lakartidningen; 2014 Oct 1-7; 111(40):1720-2. PubMed ID: 25759883
[No Abstract] [Full Text] [Related]
2. Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings.
Verhoef TI; Redekop WK; Hasrat F; de Boer A; Maitland-van der Zee AH
Am J Cardiovasc Drugs; 2014 Dec; 14(6):451-62. PubMed ID: 25326294
[TBL] [Abstract][Full Text] [Related]
3. Prevention of venous thromboembolism after major orthopedic surgery: indirect comparison of three new oral anticoagulants.
Maratea D; Fadda V; Trippoli S; Messori A
J Thromb Haemost; 2011 Sep; 9(9):1868-70. PubMed ID: 21711443
[No Abstract] [Full Text] [Related]
4. Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs.
Kooiman J; van de Peppel WR; van der Meer FJ; Huisman MV
J Thromb Haemost; 2011 Aug; 9(8):1652-3. PubMed ID: 21585647
[No Abstract] [Full Text] [Related]
5. The new oral anticoagulants and the future of haemostasis laboratory testing.
Favaloro EJ; Lippi G
Biochem Med (Zagreb); 2012; 22(3):329-41. PubMed ID: 23092064
[TBL] [Abstract][Full Text] [Related]
6. Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Points for Surgeons.
Hurst KV; Lee R; Milosevic I; Handa A
Eur J Vasc Endovasc Surg; 2015 Jul; 50(1):126-7. PubMed ID: 25933476
[No Abstract] [Full Text] [Related]
7. Net clinical benefit of oral anticoagulants: a multiple criteria decision analysis.
Hsu JC; Hsieh CY; Yang YH; Lu CY
PLoS One; 2015; 10(4):e0124806. PubMed ID: 25897861
[TBL] [Abstract][Full Text] [Related]
8. Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis.
Caldeira D; Gonçalves N; Pinto FJ; Costa J; Ferreira JJ
Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):757-64. PubMed ID: 26009864
[TBL] [Abstract][Full Text] [Related]
9. Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol.
Kepplinger J; Prakapenia A; Barlinn K; Siegert G; Gehrisch S; Zerna C; Beyer-Westendorf J; Puetz V; Reichmann H; Siepmann T; Bodechtel U
J Thromb Thrombolysis; 2016 Feb; 41(2):293-300. PubMed ID: 26001908
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis.
Sharma M; Cornelius VR; Patel JP; Davies JG; Molokhia M
Circulation; 2015 Jul; 132(3):194-204. PubMed ID: 25995317
[TBL] [Abstract][Full Text] [Related]
11. Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States.
Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
Clin Appl Thromb Hemost; 2016 Jan; 22(1):5-11. PubMed ID: 25993994
[TBL] [Abstract][Full Text] [Related]
12. Coagulation assessment with the new generation of oral anticoagulants.
Pollack CV
Emerg Med J; 2016 Jun; 33(6):423-30. PubMed ID: 25987596
[TBL] [Abstract][Full Text] [Related]
13. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
Hillis C; Crowther MA
Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
[TBL] [Abstract][Full Text] [Related]
14. Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
Squizzato A; Lussana F; Cattaneo M
Thromb Haemost; 2015 Aug; 114(2):237-44. PubMed ID: 25946985
[TBL] [Abstract][Full Text] [Related]
15. Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs).
Werth S; Breslin T; NiAinle F; Beyer-Westendorf J
Am J Cardiovasc Drugs; 2015 Aug; 15(4):235-42. PubMed ID: 25940651
[TBL] [Abstract][Full Text] [Related]
16. Timing the First Postoperative Dose of Anticoagulants: Lessons Learned From Clinical Trials.
Paikin JS; Hirsh J; Chan NC; Ginsberg JS; Weitz JI; Eikelboom JW
Chest; 2015 Sep; 148(3):587-595. PubMed ID: 25927951
[TBL] [Abstract][Full Text] [Related]
17. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation.
Nagao T; Inden Y; Yanagisawa S; Kato H; Ishikawa S; Okumura S; Mizutani Y; Ito T; Yamamoto T; Yoshida N; Hirai M; Murohara T
Heart Rhythm; 2015 Sep; 12(9):1972-8. PubMed ID: 25881495
[TBL] [Abstract][Full Text] [Related]
18. Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH.
Barnes GD; Ageno W; Ansell J; Kaatz S;
J Thromb Haemost; 2015 Jun; 13(6):1154-6. PubMed ID: 25880598
[No Abstract] [Full Text] [Related]
19. [Non-VKA oral anticoagulants: an update for the clinical biologists].
Mullier F; Douxfils J; Tamigniau A; Dogné JM; Horellou MH; Flaujac C; Chatelain B; Goffinet C; Samama MM; Gouin-Thibault I
Ann Biol Clin (Paris); 2015; 73(3):333-44. PubMed ID: 25857818
[TBL] [Abstract][Full Text] [Related]
20. An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation.
Acharya T; Deedwania P
Core Evid; 2015; 10():63-73. PubMed ID: 26019695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
